Page 1

Austco Healthcare Limited Appendix 4E - Year End Financial Report For the Year Ended 30 June 2026 Results for Announcement to the Market Current Reporting Period - Year Ended 30 June 2026 Previous Reporting Period - Year Ended 30 June 2025 % 30 June 2026 30 June 2025 Change $ ' 000 $ ' 000 Up / ( down ) Revenue from activities 15.8 % 94,242 81,405 Foreign Exchange gain / ( loss ) 80 40 Other Income 36 75 Interest income 175 324 Revenue excluding interest income 15.7 % 94,358 81,520 Earnings before interest , tax , depreciation and amortisation ( EBITDA ) 14.0 % 14,849 13,029 Depreciation and amortisation expenses ( 3,974 ) ( 2,866 ) Earnings before interest and tax ( EBIT ) 7.0 % 10,875 10,163 Contingent consideration benefit / ( expense ) 922 ( 2,201 ) Net interest ( expense ) / income ( 215 ) 95 Profit before income tax Income tax expense 43.8 % 11,582 8,057 ( 2,578 ) ( 2,124 ) Net Profit after tax for the period 51.8 % 9,004 5,933 Other comprehensive income net of tax : Currency translation difference ( 2,574 ) 681 Total comprehensive income for the period ( 2.8 % ) 6,430 6,614 Net Profit after tax attributable to : Members of Austco Healthcare Limited Non - controlling interests 9,006 5,933 ( 2 ) 9,004 5,933 Total comprehensive income attributable to : Members of Austco Healthcare Limited Non - controlling interests 6,432 6,614 ( 2 ) 6,430 6,614 Net Tangible Asset per Security ( cents per security – including ROU ) 8.24 5.42 Earnings per share attributable to the ordinary equity holders of the company ( cents per security ) : Basic Earnings per Share 2.418 1.633 Diluted Earnings per Share 2.384 1.602 Record date for determining entitlements to the dividend Dividends ( distribution ) Final dividend Previous corresponding period Not Applicable Amount per Franked Amount Security per Security n / a n / a n / a n / a Explanation of the above information : Refer to the Directors ' Report - Review of Operations for further information on the Company's operations over the past 12 months . 1